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Plants and animals use innate immunity as a first defense against
pathogens, a costly yet necessary tradeoff between growth and
immunity. In Arabidopsis, the regulatory leucine-rich repeat recep-
tor-like kinase (LRR-RLK) BAK1 combines with the LRR-RLKs FLS2
and EFR in pathogen-associated molecular pattern (PAMP)-trig-
gered immunity (PTI) and the LRR-RLK BRI1 in brassinosteroid
(BR)-mediated growth. Therefore, a potential tradeoff between
these pathways mediated by BAK1 is often postulated. Here, we
show a unidirectional inhibition of FLS2-mediated immune signal-
ing by BR perception. Unexpectedly, this effect occurred down-
stream or independently of complex formation with BAK1 and
associated downstream phosphorylation. Thus, BAK1 is not rate-
limiting in these pathways. BRs also inhibited signaling triggered
by the BAK1-independent recognition of the fungal PAMP chitin.
Our results suggest a general mechanism operative in plants in
which BR-mediated growth directly antagonizes innate immune
signaling.
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cross-talk
Plants continuously adapt to changing environments usingsurface-localized transmembrane receptor-like kinases (RLKs),
of which different members control aspects of growth, devel-
opment, and innate immunity (1–3). Intriguingly, RLKs involved
in different pathways share common regulators, suggesting a
potential cross-talk mechanism. The Arabidopsis regulatory leu-
cine-rich repeat RLK (LRR-RLK) BAK1/SERK3 is a prime
candidate for a tradeoff mediator. BAK1 interacts with and is a
positive regulator of the growth hormone brassinosteroid (BR)
receptor, the LRR-RLK BRI1 (4, 5). BRI1 can also complex
with SERK1 and BKK1/SERK4 that play partially redundant
roles with BAK1 in BR responses (6–8). BRI1 interacts with the
inhibitory protein BKI1 that is displaced following BRI1 acti-
vation, followed by recruitment of BAK1 into the BRI1 complex
(9). This leads to further BRI1 activation and phosphorylation
of cytoplasmic BSKs ultimately culminating at the transcription
factors BZR1 and BES1/BZR2 (10).
In innate immunity, BAK1 is a positive regulator forming a
rapid ligand-induced complex with the LRR-RLKs FLS2 (11, 12)
and EFR (13), the pattern-recognition receptors (PRRs) per-
ceiving the bacterial pathogen-associated molecular patterns
(PAMPs) flagellin (flg22) and EF-Tu (elf18), respectively. Ad-
ditional SERKs can be recruited by FLS2 with BKK1 as major
regulator besides BAK1 (13). BAK1 also positively regulates
other PRR-dependent pathways (12, 14–16). However, innate
immune responses triggered by PAMPs such as fungal chitin do
not depend on BAK1 (14, 17). Together with BKK1, BAK1 also
controls cell death (7, 18).
Signaling downstream of BAK1 differs between BRI1 and
FLS2 pathways. BIK1 is bound to FLS2 and dissociates in a BAK1-
dependent manner upon flg22 binding. BIK1 and paralogues
positively regulate most PAMP-triggered immunity (PTI) re-
sponses downstream of FLS2 (19, 20). FLS2 is ubiquitinated by
the BAK1-associated ubiquitin ligases PUB12 and PUB13 and
degraded (21). FLS2 activation leads to rapid bursts of calcium
and reactive oxygen species (ROS), activation of MAP kinases
and calcium-dependent protein kinases (CDPKs), ultimately
leading to PTI (22).
Upon BR binding, BRI1 auto- and transphosphorylates BAK1,
leading to increased BAK1 autophosphorylation, which in turn
transphosphorylates BRI1, resulting in optimal BRI1 activation
(23). Activation of FLS2 or EFR by their corresponding ligand
also leads to phosphorylation of the ligand-binding RLKs and
BAK1. BAK1 can provide signaling specificity in a phosphoryla-
tion-dependent manner (24).
Thus, BAK1 may be a rate-limiting positive regulator, acting
as a decision node between different pathways. BRI1 signaling
output can be enhanced by over-expression or hyperactive alleles
of BRI1 or positive regulators (8, 25–28), genetic or chemical
inactivation of negative regulators (9, 29), or exogenous appli-
cation of BR (30). This study addresses the hypotheses that
BAK1 may cross-regulate or is rate-limiting in the BRI1 and
FLS2/EFR pathways. We used primarily WT Arabidopsis plants
to reflect as faithfully as possible the natural situation under
which tradeoff between development and immunity may occur.
Results and Discussion
Activation of BAK1 by BRs Does Not Lead to Immune Responses.
BRs have been implicated in tolerance to pathogens (31–33).
Therefore, we tested whether BRs induce responses associated
with PTI. Based on the sequential phosphorylation model between
BRI1 and BAK1 (23), activation of BAK1 by BRI1 could render
the other receptor (i.e., FLS2) more active. An early PAMP re-
sponse is the rapid and transient production of ROS. To enable
comparison between treatments and/or genotypes, the amount of
ROS produced is plotted as the total amount of photons detected
in the luminol-based assay during 40 min. Whereas treatment
with the PAMPs flg22 and elf18 induced a clear ROS burst in WT
(Columbia; Col-0) Arabidopsis leaf discs, no ROS was detected
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after treatment with the biologically active 24-epibrassinolide
(epiBL), even at high concentration (Fig. 1A and Fig. S1A). This
was not caused by a previous response to endogenous BRs, as
treatment with the BR biosynthetic inhibitor brassinazole (34)
before epiBL treatment also did not give ROS (Fig. S1B). The
leaves used in these experiments were responsive to epiBL as
measured by repression of the BR biosynthetic gene CPD (Fig.
S2). Flg22 treatment of Arabidopsis seedlings activates MAPKs,
which are immunologically detectable within minutes (Fig. 1B).
No significant MAPK activation could be observed after treatment
with epiBL (Fig. 1B). PAMP perception is associated with rapid
transcriptional reprogramming (35), and FRK1 and At2g17740 are
commonly used PTI marker genes (14). In contrast to flg22, no
changes in FRK1 and At2g17740 transcript levels were observed
after epiBL treatment (Fig. 1C). In rice and tobacco, pretreatment
with BL induces resistance to several pathogens (31). We there-
fore tested if pretreatment of Arabidopsis leaves with epiBL could
induce resistance to Pseudomonas syringae pv. tomato (Pto)
DC3000. Whereas pretreatment for 24 h with 1 μM flg22 reduced
the replication of PtoDC3000 by approximately two log units (Fig.
1D) (35), no significant difference in Pto DC3000 numbers re-
covered from leaves pretreated with 1 μM epiBL was observed
(Fig. 1D). Similarly, treatment with BL did not increase resistance
to the fungus Alternaria brassicicola (18). Clearly, active BRI1-
mediated BR signaling does not induce PTI responses in WT
Arabidopsis, despite the participation of BAK1 in both pathways.
Activation of BAK1 by PAMP Perception Does Not Modulate BR
Responses. We next tested whether activation of BAK1 following
flg22 and/or elf18 perception can modulate BR signaling. De-
phosphorylation of the transcription factor BES1 is an early
marker of BR perception (25). Treatment of transgenic seedlings
expressing BES1-GFP with flg22 did not induce BES1 depho-
sphorylation, and did not affect epiBL-induced BES1 depho-
sphorylation (Fig. 2A). Similarly, the activation of multiple
BAK1-dependent pathways by cotreatment with flg22 and elf18
had no effect on epiBL-induced BES1 dephosphorylation (Fig.
S3). The apparent increase in the abundance of nonphosphor-
ylated BES1 in seedlings treated with flg22 for 6 h (Fig. 2A) was
not observed in other independent experiments (e.g., Fig. S3)
and is therefore not reproducible.
Prolonged treatment with flg22 or elf18 leads to seedling growth
inhibition, a response that could potentially result from inhibi-
tion of BRI1-mediated growth. However, flg22- or elf18-treated
seedlings did not show typical impaired BR perception attributes
such as curled dark green leaves, reduced petioles, and suppressed
hypocotyl elongation (Fig. 2B). Given that bak1mutants have only
a minor rosette phenotype compared with bri1 alleles (4, 5, 23),
and that the assay used is not quantitative, we tested if flg22- or
elf18-treated seedlings were affected in BR responsiveness by
measuring BR-marker gene CPD expression. Arabidopsis seedlings
pretreated for 1 wk with flg22 remained fully responsive to en-
dogenous and exogenously applied BRs (Fig. 2C). Therefore,
flg22 or elf18 perception does not enhance or inhibit BR signaling.
BRs Inhibit flg22- and elf18-Induced Responses. We next asked
whether prior or simultaneous treatment with epiBL affects flg22
epiBL (nM)
0
4
8
12
16
100 nM
flg22 elf18 0 10 100 1000
R
O
S 
pr
od
uc
tio
n
(p
ho
to
n 
co
un
ts
 x
10
00
)
5 100 30 60 180
flg22
epiBL
Time (min)
MPK6
CBB
MPK6
CBB
0
10
20
30
40
50
60
0h 1h 3h 0h 1h 3h
FRK1 At2g17740
flg22
epiBL
R
el
at
iv
e 
m
R
N
A
 le
ve
ls
(n
or
m
al
iz
ed
 to
 u
nt
re
at
ed
)
BA
C D
Pt
o
D
C
30
00
 (l
og
 c
fu
/c
m
2 )
0
1
2
3
4
5
6
7
mock flg22 epiBL
1 μM
***
MPK3
MPK3
Fig. 1. EpiBL perception does not induce PTI responses. (A) Oxidative burst
triggered by flg22, elf18, or epiBL in Col-0 leaf discs. ROS production is
presented as total photon counts during 40 min of treatment. Values are
mean ± SE (n = 20). (B) Activation profile of MAPKs in response to a time-
course treatment with 1 μM flg22 or epiBL in 2-wk-old Col-0 seedlings.
Arrowheads indicate phosphorylated MPK3 and MPK6. Blots stained with
colloidal brilliant blue (CBB) are presented to show equal loading. (C)
Quantitative RT-PCR analysis of FRK1 and At2g17740 expression in 2-wk old
Col-0 seedlings treated with 100 nM flg22 or epiBL for 0, 1, or 3 h. Transcript
levels are normalized to the U-box gene and are presented as relative to the
value at 0 h. Values are mean ± SD (n = 3). (D) Growth of Pto DC3000 in Col-
0 leaves pretreated with water, 1 μM flg22, or epiBL for 24 h and then sy-
ringe-infiltrated with 105 cfu/mL of bacteria. Bacterial growth was de-
termined 2 d after inoculation. Values are mean ± SE (n = 8; ***P < 0.001).
Similar results were observed in at least two independent experiments.
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Fig. 2. Activation of BAK1 by PAMP perception does not modulate BR
signaling. (A) BES1-GFP phosphorylation (detected as band shift) after the
indicated times of seedling treatment with 1 μM epiBL and/or 1 μM flg22 by
using anti-GFP antibodies. Blot stained with CBB is presented to show equal
loading. (B) Phenotype of 2-wk-old Col-0, bri1-9, and bri1-301 Arabidopsis
seedlings treated with buffer or different concentrations of flg22 or elf18
for 8 d. (Scale bar: 1 cm.) (C) Quantitative RT-PCR of CPD gene expression in
2-wk-old Col-0 seedlings grown with or without 10 nM flg22 for 1 wk and
then treated with 1 μM epiBL for the indicated time. Transcript levels are
normalized to the U-box gene and are presented as relative to mock
treatment at time 0. Values are mean ± SD (n = 3; ***P < 0.001). Similar
results were observed in at least three independent experiments.
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or elf18 triggered PTI responses in WT leaves. After 5 h of
epiBL pretreatment, we observed a marked decrease in ROS
production triggered by flg22 (Fig. 3A) or elf18 (Fig. S4). In
addition, the expression of PTI marker genes was approximately
halved when WT seedlings were simultaneously treated with
epiBL and flg22 for 3 h (Fig. 3B). Similarly, seedling growth
inhibition triggered by up to 100 nM flg22 was clearly suppressed
by cotreatment with epiBL, whereas epiBL by itself did not in-
crease seedling growth in these conditions (Fig. 3C). Together
with the inability of FLS2 activation by flg22 to initiate or sup-
press BR signaling (Fig. 2 A and C), these results point to
a unidirectional inhibition of several PTI outputs by epiBL
perception.
BAK1 Is Not Rate-Limiting Between BRI1 and FLS2 Pathways. The
simplest explanation for BRs to inhibit the FLS2 pathway is that
FLS2–BAK1 complexes are not formed as a result of recruit-
ment of BAK1 into BRI1 complexes. This hypothesis assumes
that BAK1 is rate-limiting in PTI but not in BR signaling.
Therefore, WT Arabidopsis seedlings were treated with flg22,
epiBL, or both, and subjected to coimmunoprecipitation experi-
ments using anti-FLS2 and anti-BAK1 antibodies. After 10 min,
flg22 induced complex formation between FLS2 and BAK1 (Fig.
4A). Consistent with the ligand dependency of FLS2–BAK1
oligomerization (11, 36), epiBL alone did not induce formation
of this complex, nor did cotreatment with flg22 and epiBL lead to
a change compared with flg22 alone (Fig. 4A). Oligomerization
between BRI1 and BAK1 is usually studied 90 min after BL
treatment (23). Flg22-induced FLS2 and BAK1 oligomers could
still be observed after 90 min of flg22 treatment, albeit at a lower
level (Fig. 4A). Importantly, the presence of epiBL together with
flg22 for 90 min did not affect the amount of FLS2 immuno-
precipitated with BAK1 (Fig. 4A). Even a 5-h pretreatment with
epiBL did not affect the amount of FLS2-BAK1 oligomers after
a 10-min flg22 treatment (Fig. 4A). Similar results were obtained
in reverse coimmunoprecipitation experiments (Fig. S5) or lines
expressing FLS2-GFP (Fig. S6). No alteration of FLS2 amount
was observed in seedlings (pre)treated with epiBL (Fig. 4A and
Figs. S5 and S6, input). We then compared the amount of native
BAK1 that can be pulled down by C-terminally GFP-tagged
BRI1 or FLS2 in Arabidopsis transgenic plants (Fig. 4B). These
results show that only a very small amount of BAK1 was present
in a ligand-dependent complex with BRI1-GFP, whereas a large
amount of BAK1 was sequestered by FLS2-GFP. The amount of
BAK1 available for recruitment by both FLS2 and EFR was not
limiting, as cotreatment with flg22 and elf18 did not impair the
amount of BAK1 in complex with FLS2 (Fig. S7). Cotreatment
with epiBL and flg22 precluded the use of a single plant line for
assessing the relative amounts of BAK1 associating with either
receptor. To ensure that the observed difference in BRI1- or
FLS2-mediated recruitment of BAK1 is not a result of a differ-
ence between BRI1 and FLS2 protein concentration, we used
quantitative Western analysis (37). In seedlings grown under the
same conditions, the amount of BRI1-eGFP is 17.5 ± 6.1 pmol g−1
fresh weight (FW) and the amount of FLS2-3myc-GFP is 8.0 ± 1.9
pmol g−1 FW (Fig. S8 A and B). The immunoprecipitation (IP)
efficiency within the two different backgrounds is highly re-
producible at 41 ± 5% (Fig. S8 C and D), whereas, after si-
multaneous epiBL and flg22 application, less than 5% of the
BAK1 pool is recruited by BRI1 (Fig. S8E). Therefore, the ob-
served impairment of flg22-induced responses by BR perception
is not caused by a lack of BAK1.
EpiBL Inhibition of FLS2 Is Independent or Downstream of BAK1-BIK1.
2Although FLS2 and BAK1 kinase activity is not required for
heteromerization (24, 36), it is essential for downstream signaling
(24, 36, 38). Thus, we asked whether cotreatment with epiBL and
flg22 affects FLS2 and/or BAK1 phosphorylation. By using a
BAK1p::BAK1-GFP line, BAK1 phosphorylation status was de-
termined by using antiphosphothreonine (anti-pThr) antibodies.
Of note, we observed in some experiments that BAK1-GFP could
form homo-oligomers with the endogenous BAK1, but this was
not always reproducible. Importantly, whereas a large amount of
BAK1 is recruited by FLS2 (Fig. 4B), only a very small fraction is
phosphorylated (Fig. 4C). In contrast, treatment with epiBL for 10
or 90 min leads to strong BAK1 phosphorylation (Fig. 4C), which
prevented us from testing if epiBL co- or pretreatment affects
flg22-induced BAK1 phosphorylation. In a complementary strat-
egy, we performed IP followed by in vitro radioactive kinase assays
to reveal the phosphorylation status of FLS2 and BAK1 after flg22
and/or epiBL treatment. In this experiment, in vitro FLS2 phos-
phorylation could be detected in immunoprecipitated FLS2 from
flg22-treated but not from mock- or epiBL-treated seedlings (Fig.
4D, Upper). Pretreatment with epiBL for 90 min did not inhibit
flg22-induced FLS2 phosphorylation (Fig. 4D, Upper). When
BAK1 was immunoprecipitated, enhanced FLS2 phosphorylation
was observed within 10 min of flg22 perception (Fig. 4D, Lower),
as well as increased BAK1 phosphorylation resulting from BRI1
activation (Fig. 4D, Lower). As seen in Fig. 4C, epiBL-induced
BAK1 phosphorylation was higher than that triggered by flg22.
Importantly, as also seen in FLS2 immunoprecipitates, the phos-
phorylation status of BAK1-associated FLS2 was not affected by
epiBL pretreatment (Fig. 4D, Lower). Therefore, epiBL-induced
inhibition of FLS2 signaling is not associated with reduced phos-
phorylation of FLS2 or of FLS2-associated BAK1. Next, we tested
if BIK1, a FLS2 substrate and positive regulator of PTI signaling
(19, 20), could be the target of the epiBL-mediated inhibition of
PTI signaling. However, no effect of epiBL on flg22-induced BIK1
phosphorylation, either after simultaneous treatment or after a
5-h pretreatment (Fig. 4E), was observed.
Finally, we tested if epiBL perception also inhibits signaling
triggered by the fungal PAMP chitin. This PAMP is perceived
via the LysM-RLK CERK1 and induces PTI marker genes in a
BAK1-independent manner (14, 17, 39, 40). In agreement with
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Fig. 3. EpiBL perception inhibits PTI signaling. (A) Effect of pretreatment
with 1 μM epiBL for the indicated time on ROS triggered by 50 nM flg22 in
Col-0 leaf discs. Total ROS production during 40 min of treatment is
expressed as percentage of flg22-treated Col-0 without epiBL treatment.
Values are mean ± SE (n = 20). (B). Quantitative RT-PCR of FRK1 and
At2g17740 gene expression in 2-wk-old Col-0 seedlings treated with 1 μM
flg22 and/or 1 μM epiBL for the indicated time. Transcript levels are nor-
malized to the U-box gene and are presented as relative to time 0. Values
are mean ± SD (n = 3). (C) Seedling growth inhibition induced by increasing
concentrations of flg22 in absence (♢) or presence (◆) of 1 μM epiBL.
Values are mean ± SD (n = 12; **P < 0.01 and ***P < 0.001). Similar results
were observed in at least two independent experiments.
Albrecht et al. PNAS Early Edition | 3 of 6
PL
A
N
T
BI
O
LO
G
Y
its genetic dispensability for chitin-induced gene expression (14),
we show that BAK1 does not form a ligand-dependent complex
with CERK1 (Fig. 5A). Importantly, epiBL pretreatment in-
hibited the chitin-induced ROS burst (Fig. 5B), similarly to that
observed for the flg22- and elf18-induced ROS burst (Figs. 3A
and 5B and Fig. S4). Notably, the epiBL-mediated inhibition of
the flg22- and chitin-induced ROS bursts also occurred in the
null bak1-4 mutant.
Collectively, our results demonstrate that BR signaling inhibits
FLS2-mediated signaling downstream or independently of the
FLS2–BAK1–BIK1 complex.
Conclusions
We have shown that activation of the BRI1 pathway leads to
inhibition of PTI signaling mediated by several PRRs. This
reveals a potential tradeoff between RLK-mediated growth and
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innate immunity in plants. BR perception in rice was shown to
increase resistance to biotic and abiotic stresses (31, 33). Con-
sistently, BRs activate the expression of several immunity-related
genes, including PR1 and AtMYB30 (33, 41). Conversely, the BR-
activated transcription factor BZR1 represses the promoters of
several immune genes, including FLS2 (42). However, our ob-
servation that the FLS2 protein level is unaffected by epiBL
treatment does not support this finding.
Because the LRR-RLK BAK1 serves in multiple signaling
pathways (43), it was an attractive candidate to regulate tradeoff
between immunity and growth already at receptor level. It is still
unclear how this tradeoff is regulated. Here we have shown that
the most likely scenario, in which BAK1 protein is present in rate-
limiting amounts, cannot provide the explanation.Also, there is no
direct effect of active PAMP signaling on the BR pathway, ruling
out a bidirectional cross-talk mechanism as occurs between EGF
and insulin signaling (44). Instead, an asymmetric mechanism
operating downstream or independently of the common compo-
nent BAK1modulates early immune signalingmediated by PAMP
recognition. Although BAK1 has been proposed to mediate in-
terplay between BR and PAMP signaling (12), we provided evi-
dence that the growth-inhibiting effect of PAMP perception does
not operate through antagonism of BR signaling. Our experiments
suggest that different pools of BAK1 exist that are not freely in-
terchangeable.BAK1recruitedbyFLS2 seems tobedifferent from
that recruited byBRI1, asBLdid not displace the amount ofBAK1
immunoprecipitated with FLS2. Alternatively, this could be
explained by the fact that more BAK1 is recruited into FLS2
complexes than into the BRI1 complex, or that the complexes are
more stable. This idea is corroborated by theobservedweak impact
of BAK1 loss-of-function mutations on BR sensitivity (4, 5, 23),
whereas BAK1 plays a more important role in FLS2 signaling (11,
12, 24), and by the finding that the role of BAK1 in BR and PTI
signaling can be mechanistically uncoupled (24).
Tradeoffs between endogenous hormonal pathways and re-
sponses to exogenous cues have been proposed previously. For
example, the nuclear growth-repressing DELLA proteins nega-
tively regulate gibberellic acid (GA) signaling, but are important
to mediate the balance between the immune hormones salicylic
acid and jasmonic acid in response to biotic and abiotic stresses
(45–48). Also, auxin and salicylic acid signaling antagonize each
other (49, 50). Notably, flg22 perception inhibits auxin signaling
by inducing the expression of the microRNA miR393 that targets
auxin receptors to increase disease resistance to biotrophic
pathogens (49). Similarly, flg22 perception dampens GA signal-
ing by stabilizing DELLA proteins that are negative regulators of
this pathway (47). Given the important role of endogenous
hormones in modulating plant defense, several pathogens pro-
duce GA or auxin as potential virulence strategies (51). In-
terestingly, the obligate biotrophic oomycete Albugo laibachii
appears to encode a complete BR biosynthesis pathway (52).
Together with our results, this leads to the tentative hypothesis
that BR production may contribute to the ability of this pathogen
to suppress plant immunity. On the plant side, recent work shows
that enhanced BR signaling as observed in gain-of-function
mutations in BAK1 (27) and in BRI1 (28), both impair responses
to flagellin, supporting this idea.
Therefore, BR signaling may play an important role in the
modulation of plant immunity during plant growth, by regulating
immune signaling downstream of BIK1, and is a potential site of
manipulation by pathogens during infection.
Materials and Methods
Plant Materials and Growth. Arabidopsis thaliana ecotype Columbia (Col-0)
was used as the WT control. Mutants, transgenic lines, and growth con-
ditions are described in SI Materials and Methods.
Chemicals. Flg22 and elf18 peptides were purchased from Peptron, and chitin
oligosaccharide from Yaizu Suisankagaku. epiBL was purchased from Xiamen
Topusing Chemical and prepared as 20 mM stock solution in ethanol. Bras-
sinazole was purchased from Sigma and prepared as 10 mM stock solution
in DMSO.
Measurement of ROS Generation. Oxidative-burst measurement was per-
formed as previously described (53). ROS was elicited with flg22, elf18, or
epiBL, and elicitation in the absence of any PAMP (water treatment) was
included in all experiments as negative control. Twenty leaf discs from ten
5-wk-old plants were used for each condition. Luminescence was measured
over 40 min by using a high-resolution photon counting system (HRPCS218;
Photek) coupled to an aspherical wide lens (Sigma).
Seedling Growth Inhibition Assay. Seedling growth inhibition was assessed as
previously described in (54). In brief, 5-d-old Arabidopsis seedlings were
grown in liquid Murashige–Skoog medium containing 1% sucrose supple-
mented with flg22 or elf18 peptides. Seedlings were weighted 8 d after-
treatment.
RNA Isolation and Quantitative RT-PCR. Total RNAwas prepared from six 2-wk-
old seedlings grown in liquid medium or from four leaf discs (38.5 mm2 each,
from 5-wk-old plants) floated overnight in water before treatment. RNA
extraction, cDNA synthesis, and quantitative RT-PCR were performed as
described in SI Materials and Methods.
Induced Resistance to Bacteria. Induced resistance assays were realized as
described previously (35). Briefly, water, 1 μM flg22, or 1 μM epiBL was
infiltrated with a needleless syringe into leaves of 5-wk-old Arabidopsis
plants. After 24 h, the same leaves were syringe-infiltrated with 105 cfu/mL
of Pto DC3000. Bacterial growth was determined 2 d after inoculation
by plating serial dilutions of leaf extracts on L agar with appropriate
antibiotics.
MAPK Activation. Activation profile of the MAPKs MPK3 and MPK6 in re-
sponse to 1 μM flg22 or 1 μM epiBL was performed as described previously
(53). Phospho-p44/42 MAPK (Erk1/2; Thr202/Tyr204) rabbit monoclonal
antibodies (Cell Signaling) were used according to the manufacturer’s
protocol.
Protein Extraction and IP Experiments. Protein extraction and IP using WT
Arabidopsis seedlings were performed as described previously (24). Protein
extraction and IP by using Ws-0/FLS2p::FLS2-3myc-GFP and Col-0/BAK1p::
BAK1-GFP transgenic lines was performed as described in SI Materials and
Methods. Proteins were separated by SDS/PAGE 10% and further analyzed
by Western blot by using rabbit polyclonal anti-FLS2 antibodies (17), rabbit
polyclonal anti-CERK1 antibodies (17), rabbit polyclonal anti-BAK1 anti-
bodies (36), mouse monoclonal anti-GFP antibodies coupled to horseradish
peroxidase (Miltenyi Biotec), and rabbit polyclonal anti-pThr antibodies
(Zymed-Invitrogen). Phosphorylation statuses of BES1-GFP and BIK1-HA and
in vitro phosphorylation of immunoprecipitated proteins were analyzed as
described in SI Materials and Methods. Quantitative Western blotting was
performed as described previously (37).
Statistical Analysis. Statistical significances based on one-way ANOVA anal-
yses were determined with Prism 5.01 software (GraphPad).
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